These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27031095)

  • 61. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
    Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
    Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human papillomavirus 16 E7 protein inhibits interferon-γ-mediated enhancement of keratinocyte antigen processing and T-cell lysis.
    Zhou F; Leggatt GR; Frazer IH
    FEBS J; 2011 Apr; 278(6):955-63. PubMed ID: 21232015
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The HPV16 E7 Oncoprotein Disrupts Dendritic Cell Function and Induces the Systemic Expansion of CD11b(+)Gr1(+) Cells in a Transgenic Mouse Model.
    Damian-Morales G; Serafín-Higuera N; Moreno-Eutimio MA; Cortés-Malagón EM; Bonilla-Delgado J; Rodríguez-Uribe G; Ocadiz-Delgado R; Lambert PF; Gariglio P
    Biomed Res Int; 2016; 2016():8091353. PubMed ID: 27478837
    [TBL] [Abstract][Full Text] [Related]  

  • 65. E6/E7 and E6
    Artaza-Irigaray C; Molina-Pineda A; Aguilar-Lemarroy A; Ortiz-Lazareno P; Limón-Toledo LP; Pereira-Suárez AL; Rojo-Contreras W; Jave-Suárez LF
    Front Immunol; 2019; 10():1676. PubMed ID: 31396215
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HPV16-E7 expression in squamous epithelium creates a local immune suppressive environment via CCL2- and CCL5- mediated recruitment of mast cells.
    Bergot AS; Ford N; Leggatt GR; Wells JW; Frazer IH; Grimbaldeston MA
    PLoS Pathog; 2014 Oct; 10(10):e1004466. PubMed ID: 25340820
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunization of mice by the co-administration of codon-optimized HPV16 E7 and lL12 genes against HPV16-associated cervical cancer.
    Ajorloo M; Alamdary A; Soleimanjahi H; El Boulani A; Khanizadeh S; Nikoo HR
    Microb Pathog; 2019 Jul; 132():20-25. PubMed ID: 31004722
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human papillomavirus type 16 E6 and E7 gene variations associated with cervical cancer in a Han Chinese population.
    Zhou Z; Yang H; Yang L; Yao Y; Dai S; Shi L; Li C; Yang L; Yan Z; Yao Y
    Infect Genet Evol; 2019 Sep; 73():13-20. PubMed ID: 30981880
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells.
    Halbert CL; Demers GW; Galloway DA
    J Virol; 1992 Apr; 66(4):2125-34. PubMed ID: 1312623
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interkeratin peptide-protein interactions that promote HPV16 E7 gene expression.
    Lucchese A; Serpico R; Guida A; Crincoli V; Scully C; Kanduc D
    Int J Immunopathol Pharmacol; 2010; 23(3):857-64. PubMed ID: 20943057
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A novel self-assembled nanoparticle vaccine with HIV-1 Tat₄₉₋₅₇/HPV16 E7₄₉₋₅₇ fusion peptide and GM-CSF DNA elicits potent and prolonged CD8⁺ T cell-dependent anti-tumor immunity in mice.
    Tang J; Yin R; Tian Y; Huang Z; Shi J; Fu X; Wang L; Wu Y; Hao F; Ni B
    Vaccine; 2012 Feb; 30(6):1071-82. PubMed ID: 22178528
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine].
    Wang QY; Xu YF; Fan DS; Peng QL; Zhang T; Xu XM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):584-91. PubMed ID: 18051710
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Generation and evaluation of a human corneal model cell system for ophthalmologic issues using the HPV16 E6/E7 oncogenes as uniform immortalization platform.
    Schulz S; Steinberg T; Beck D; Tomakidi P; Accardi R; Tommasino M; Reinhard T; Eberwein P
    Differentiation; 2013; 85(4-5):161-72. PubMed ID: 23811495
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rational design of DNA vaccines for the induction of human papillomavirus type 16 E6- and E7-specific cytotoxic T-cell responses.
    Oosterhuis K; Aleyd E; Vrijland K; Schumacher TN; Haanen JB
    Hum Gene Ther; 2012 Dec; 23(12):1301-12. PubMed ID: 22971245
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells.
    De Bruijn ML; Schuurhuis DH; Vierboom MP; Vermeulen H; de Cock KA; Ooms ME; Ressing ME; Toebes M; Franken KL; Drijfhout JW; Ottenhoff TH; Offringa R; Melief CJ
    Cancer Res; 1998 Feb; 58(4):724-31. PubMed ID: 9485027
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The L1 major capsid protein of HPV16 differentially modulates APC trafficking according to the vaccination or natural infection context.
    Herman L; Hubert P; Herfs M; Kustermans G; Henrotin Y; Bousarghin L; Boniver J; Delvenne P
    Eur J Immunol; 2010 Nov; 40(11):3075-84. PubMed ID: 21061438
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Validation of an HPV16-mediated carcinogenesis mouse model.
    De Azambuja K; Barman P; Toyama J; Elashoff D; Lawson GW; Williams LK; Chua K; Lee D; Kehoe JJ; Brodkorb A; Schwiebert R; Kitchen S; Bhimani A; Wiley DJ
    In Vivo; 2014; 28(5):761-7. PubMed ID: 25189887
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Langerhans cell homeostasis and activation is altered in hyperplastic human papillomavirus type 16 E7 expressing epidermis.
    Abd Warif NM; Stoitzner P; Leggatt GR; Mattarollo SR; Frazer IH; Hibma MH
    PLoS One; 2015; 10(5):e0127155. PubMed ID: 25992642
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cystatin C deficiency promotes epidermal dysplasia in K14-HPV16 transgenic mice.
    Yu W; Liu J; Shi MA; Wang J; Xiang M; Kitamoto S; Wang B; Sukhova GK; Murphy GF; Orasanu G; Grubb A; Shi GP
    PLoS One; 2010 Nov; 5(11):e13973. PubMed ID: 21085595
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis.
    Dennemärker J; Lohmüller T; Mayerle J; Tacke M; Lerch MM; Coussens LM; Peters C; Reinheckel T
    Oncogene; 2010 Mar; 29(11):1611-21. PubMed ID: 20023699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.